B. Riley analyst Jeff Van Sinderen lowered the firm’s price target on Biote (BTMD) to $3 from $4 and keeps a Neutral rating on the shares. The firm reduced estimates post the Q3 report.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTMD: